Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 503

1.

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM.

J Am Soc Nephrol. 2004 Aug;15(8):2208-18.

2.

Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.

Fukagawa M, Kido R, Komaba H, Onishi Y, Yamaguchi T, Hasegawa T, Kurita N, Fukuma S, Akizawa T, Fukuhara S.

Am J Kidney Dis. 2014 Jun;63(6):979-87. doi: 10.1053/j.ajkd.2013.08.011. Epub 2013 Oct 8.

PMID:
24119541
3.

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK.

Am J Kidney Dis. 2008 Sep;52(3):519-30. doi: 10.1053/j.ajkd.2008.03.020. Epub 2008 Jun 2.

PMID:
18514987
4.

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Block GA, Hulbert-Shearon TE, Levin NW, Port FK.

Am J Kidney Dis. 1998 Apr;31(4):607-17.

PMID:
9531176
5.

Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study.

Naves-Díaz M, Passlick-Deetjen J, Guinsburg A, Marelli C, Fernández-Martín JL, Rodríguez-Puyol D, Cannata-Andía JB.

Nephrol Dial Transplant. 2011 Jun;26(6):1938-47. doi: 10.1093/ndt/gfq304. Epub 2010 May 31.

6.

PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.

Danese MD, Kim J, Doan QV, Dylan M, Griffiths R, Chertow GM.

Am J Kidney Dis. 2006 Jan;47(1):149-56.

PMID:
16377396
7.

Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study.

Kimata N, Albert JM, Akiba T, Yamazaki S, Kawaguchi T, Fukuhara S, Akizawa T, Saito A, Asano Y, Kurokawa K, Pisoni RL, Port FK.

Hemodial Int. 2007 Jul;11(3):340-8. Erratum in: Hemodial Int. 2009 Jan;13(1):91. Kawaguchi, Yoshindo [corrected to Kawaguchi,Takehiko].

PMID:
17576300
8.

Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M.

Am J Kidney Dis. 2004 Nov;44(5 Suppl 2):34-8.

PMID:
15486872
9.

Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.

Slinin Y, Foley RN, Collins AJ.

J Am Soc Nephrol. 2005 Jun;16(6):1788-93. Epub 2005 Apr 6.

10.

Mineral metabolism and mortality in dialysis patients: a reassessment of the K/DOQI guideline.

Noordzij M, Korevaar JC, Dekker FW, Boeschoten EW, Bos WJ, Krediet RT, Bossuyt PM, Geskus RB; NECOSAD study group.

Blood Purif. 2008;26(3):231-7. doi: 10.1159/000118847. Epub 2008 Feb 28.

PMID:
18305386
11.

Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access.

Lacson E Jr, Wang W, Hakim RM, Teng M, Lazarus JM.

Am J Kidney Dis. 2009 Jan;53(1):79-90. doi: 10.1053/j.ajkd.2008.07.031. Epub 2008 Oct 18.

PMID:
18930570
12.

Factors modulating cytosolic calcium. Role in lipid metabolism and cardiovascular morbidity and mortality in peritoneal dialysis patients.

Gadallah MF, el-Shahawy M, Andrews G, Ibrahim M, Ramdeen G, Hanna D, Gorospe W, Morkos A, Abbassian M, Moles K.

Adv Perit Dial. 2001;17:29-36.

PMID:
11510292
14.

Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.

Noordzij M, Korevaar JC, Bos WJ, Boeschoten EW, Dekker FW, Bossuyt PM, Krediet RT.

Nephrol Dial Transplant. 2006 Sep;21(9):2513-20. Epub 2006 Jun 24.

16.

Mineral metabolism disturbances in patients with chronic kidney disease.

Kestenbaum B, Belozeroff V.

Eur J Clin Invest. 2007 Aug;37(8):607-22. Review.

PMID:
17635571
19.

The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients.

Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT; Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) Study Group.

Am J Kidney Dis. 2005 Nov;46(5):925-32.

PMID:
16253734
20.

Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients.

Noordzij M, Voormolen NM, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT, Korevaar JC; NECOSAD study group.

Nephrol Dial Transplant. 2009 May;24(5):1580-7. doi: 10.1093/ndt/gfn768. Epub 2009 Jan 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk